Edward W. Kraegen
#160,852
Most Influential Person Now
Edward W. Kraegen's AcademicInfluence.com Rankings
Edward W. Kraegenbiology Degrees
Biology
#12726
World Rank
#16222
Historical Rank
Physiology
#412
World Rank
#635
Historical Rank
Molecular Biology
#2092
World Rank
#2124
Historical Rank
Biochemistry
#2197
World Rank
#2342
Historical Rank
Download Badge
Biology
Edward W. Kraegen's Degrees
- PhD Biochemistry University of California, San Francisco
- Bachelors Biochemistry University of California, Berkeley
Why Is Edward W. Kraegen Influential?
(Suggest an Edit or Addition)Edward W. Kraegen's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle* (2002) (1577)
- Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. (1999) (1226)
- Influence of Dietary Fat Composition on Development of Insulin Resistance in Rats: Relationship to Muscle Triglyceride and ω-3 Fatty Acids in Muscle Phospholipid (1991) (1002)
- Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase With Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States (2006) (974)
- Fish oil prevents insulin resistance induced by high-fat feeding in rats. (1987) (700)
- Development of Muscle Insulin Resistance After Liver Insulin Resistance in High-Fat–Fed Rats (1991) (645)
- Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. (1986) (522)
- Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. (2007) (517)
- Insulin resistance is a cellular antioxidant defense mechanism (2009) (481)
- Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex I (2008) (472)
- Mechanisms of Liver and Muscle Insulin Resistance Induced by Chronic High-Fat Feeding (1997) (435)
- Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. (1985) (414)
- Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. (1989) (373)
- Heterogeneity of insulin action in individual muscles in vivo: euglycemic clamp studies in rats. (1985) (359)
- Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding (2013) (350)
- Peroxisome Proliferator—Activated Receptor (PPAR)-α Activation Lowers Muscle Lipids and Improves Insulin Sensitivity in High Fat—Fed Rats Comparison With PPAR-γ Activation (2001) (333)
- Overexpression of Carnitine Palmitoyltransferase-1 in Skeletal Muscle Is Sufficient to Enhance Fatty Acid Oxidation and Improve High-Fat Diet–Induced Insulin Resistance (2009) (328)
- AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. (2002) (312)
- Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. (2000) (282)
- Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity. (2003) (270)
- Alterations in the Expression and Cellular Localization of Protein Kinase C Isozymes ε and θ Are Associated With Insulin Resistance in Skeletal Muscle of the High-Fat–Fed Rat (1997) (270)
- Physiological Importance of Deficiency in Early Prandial Insulin Secretion in Non-Insulin-Dependent Diabetes (1988) (251)
- The role of intramuscular lipid in insulin resistance. (2003) (250)
- A New Antidiabetic Agent, BRL 49653, Reduces Lipid Availability and Improves Insulin Action and Glucoregulation in the Rat (1994) (247)
- Free fatty acids and skeletal muscle insulin resistance (2008) (237)
- Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo. (2004) (226)
- Diet-Induced Muscle Insulin Resistance in Rats Is Ameliorated by Acute Dietary Lipid Withdrawal or a Single Bout of Exercise: Parallel Relationship Between Insulin Stimulation of Glucose Uptake and Suppression of Long-Chain Fatty Acyl-CoA (1997) (213)
- Effects of Fish Oil Supplementation on Glucose and Lipid Metabolism in NIDDM (1989) (180)
- Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. (1997) (172)
- In vivo insulin sensitivity in the rat determined by euglycemic clamp. (1983) (172)
- Fatty acid metabolism, energy expenditure and insulin resistance in muscle. (2014) (172)
- Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. (2002) (171)
- Downregulation of AMPK Accompanies Leucine- and Glucose-Induced Increases in Protein Synthesis and Insulin Resistance in Rat Skeletal Muscle (2010) (171)
- The Determinants of Glycemic Responses to Diet Restriction and Weight Loss in Obesity and NIDDM (1998) (162)
- Glucose transporters and in vivo glucose uptake in skeletal and cardiac muscle: fasting, insulin stimulation and immunoisolation studies of GLUT1 and GLUT4. (1993) (158)
- Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy. (2002) (157)
- Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. (2001) (151)
- Acute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole-body energy expenditure or adiposity. (2010) (150)
- PPARα/γ ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly (2003) (148)
- Changes in aerobic capacity and visceral fat but not myocyte lipid levels predict increased insulin action after exercise in overweight and obese men. (2003) (146)
- Malonyl-CoA and AMP-activated protein kinase (AMPK): possible links between insulin resistance in muscle and early endothelial cell damage in diabetes. (2001) (145)
- Effects of exercise training on in vivo insulin action in individual tissues of the rat. (1985) (142)
- Direct demonstration of lipid sequestration as a mechanism by which rosiglitazone prevents fatty-acid-induced insulin resistance in the rat: comparison with metformin (2004) (141)
- Long-term high-fat feeding leads to severe insulin resistance but not diabetes in Wistar rats. (2002) (140)
- Enhancement of Muscle Mitochondrial Oxidative Capacity and Alterations in Insulin Action Are Lipid Species Dependent (2009) (139)
- In vivo glucose metabolism in individual tissues of the rat. Interaction between epinephrine and insulin. (1986) (137)
- The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity. (2001) (136)
- Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of rats. (2006) (128)
- APPL1 potentiates insulin-mediated inhibition of hepatic glucose production and alleviates diabetes via Akt activation in mice. (2009) (128)
- Differing Endoplasmic Reticulum Stress Response to Excess Lipogenesis versus Lipid Oversupply in Relation to Hepatic Steatosis and Insulin Resistance (2012) (126)
- The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat. (1997) (126)
- Blood Glucose Control by Intermittent Loop Closure in the Basal Mode: Computer Simulation Studies with a Diabetic Model (1985) (124)
- Effects of nonesterified fatty acid availability on tissue-specific glucose utilization in rats in vivo. (1988) (122)
- Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat. (1999) (122)
- Effects of sucrose vs starch diets on in vivo insulin action, thermogenesis, and obesity in rats. (1988) (118)
- In vivo insulin resistance in individual peripheral tissues of the high fat fed rat: assessment by euglycaemic clamp plus deoxyglucose administration (1986) (118)
- Treatment of Severe Diabetes Mellitus by Insulin Infusion (1974) (114)
- Triglycerides, fatty acids and insulin resistance--hyperinsulinemia. (2001) (110)
- Functional studies of Akt isoform specificity in skeletal muscle in vivo; maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression. (2007) (108)
- Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat. (1998) (106)
- Major Urinary Protein-1 Increases Energy Expenditure and Improves Glucose Intolerance through Enhancing Mitochondrial Function in Skeletal Muscle of Diabetic Mice* (2009) (106)
- Effects of individual fatty acids on glucose uptake and glycogen synthesis in soleus muscle in vitro. (2000) (103)
- In vivo location of the rate-limiting step of hexose uptake in muscle and brain tissue of rats. (1991) (94)
- Overexpression of acyl-CoA synthetase-1 increases lipid deposition in hepatic (HepG2) cells and rodent liver in vivo. (2006) (90)
- Timing of insulin delivery with meals. (1981) (89)
- Chronic central melanocortin-4 receptor antagonism and central neuropeptide-Y infusion in rats produce increased adiposity by divergent pathways. (2002) (83)
- PATHOGENESIS OF THE INSULIN RESISTANCE SYNDROME (SYNDROME X) (1997) (82)
- Glucose Transporter (GLUT-4) Is Targeted to Secretory Granules in Rat Atrial Cardiomyocytes (1997) (81)
- Carrier solutions for low-level intravenous insulin infusion. (1975) (81)
- Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms. (2004) (81)
- Lipid and insulin infusion-induced skeletal muscle insulin resistance is likely due to metabolic feedback and not changes in IRS-1, Akt, or AS160 phosphorylation. (2009) (80)
- Heterogeneity of insulin action in muscle: influence of blood flow. (1986) (79)
- The gastrointestinal stimulus to insulin release. II. A dual action of secretin. (1970) (77)
- Chronic exercise compensates for insulin resistance induced by a high-fat diet in rats. (1989) (76)
- PPARalpha /gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly. (2003) (76)
- Overexpression of manganese superoxide dismutase ameliorates high-fat diet-induced insulin resistance in rat skeletal muscle. (2012) (75)
- AMP-activated protein kinase activation by AICAR increases both muscle fatty acid and glucose uptake in white muscle of insulin-resistant rats in vivo. (2004) (73)
- Muscle glucose metabolism in exercising rats: comparison with insulin stimulation. (1985) (72)
- Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification. (2007) (72)
- Exercise-induced hepatic glucose output is precisely sensitive to the rate of systemic glucose supply. (1985) (71)
- Insulin resistance and fuel homeostasis: the role of AMP‐activated protein kinase (2009) (71)
- Hyperinsulinemia suppresses glucose utilization in specific brain regions: in vivo studies using the euglycemic clamp in the rat. (1985) (71)
- Insulin resistance due to nutrient excess (2011) (70)
- Mice lacking the neuropeptide alpha-calcitonin gene-related peptide are protected against diet-induced obesity. (2010) (70)
- Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity. (2003) (70)
- Pentobarbital reduces basal liver glucose output and its insulin suppression in rats. (1990) (68)
- Muscle insulin resistance: A case of fat overconsumption, not mitochondrial dysfunction (2008) (67)
- Oleanolic Acid Reduces Hyperglycemia beyond Treatment Period with Akt/FoxO1-Induced Suppression of Hepatic Gluconeogenesis in Type-2 Diabetic Mice (2012) (66)
- A potent in vivo effect of ciglitazone on muscle insulin resistance induced by high fat feeding of rats. (1989) (66)
- Effect of exercise training on whole-body insulin sensitivity and responsiveness. (1984) (65)
- Reversal of chronic alterations of skeletal muscle protein kinase C from fat-fed rats by BRL-49653. (1997) (64)
- Potent effects of human galanin in man: growth hormone secretion and vagal blockade. (1993) (64)
- Overexpression of the Adiponectin Receptor AdipoR1 in Rat Skeletal Muscle Amplifies Local Insulin Sensitivity (2012) (64)
- Insulin responses to varying profiles of subcutaneous insulin infusion: kinetic modelling studies (1984) (63)
- Rosiglitazone Treatment Enhances Acute AMP-Activated Protein Kinase–Mediated Muscle and Adipose Tissue Glucose Uptake in High-Fat–Fed Rats (2006) (63)
- Peroxisome Proliferator-Activated Receptor (PPAR) Activation Induces Tissue-Specific Effects on Fatty Acid Uptake and Metabolism in Vivo—A Study Using the Novel PPARα/γ Agonist Tesaglitazar (2004) (63)
- Adrenalectomy reduces neuropeptide Y-induced insulin release and NPY receptor expression in the rat ventromedial hypothalamus. (2000) (62)
- Activation of AMPK by Bitter Melon Triterpenoids Involves CaMKKβ (2013) (60)
- Effect of acute exercise and prolonged training on insulin response to intravenous glucose in vivo in rat. (1983) (58)
- Selective chronic regulation of GLUT1 and GLUT4 content by insulin, glucose, and lipid in rat cardiac muscle in vivo. (1997) (58)
- Development and initial evaluation of a novel method for assessing tissue-specific plasma free fatty acid utilization in vivo using (R)-2-bromopalmitate tracer. (1999) (56)
- Feedback inhibition of insulin gene expression by insulin. (1992) (55)
- Control of blood glucose in diabetics using an artificial pancreas. (1977) (55)
- Acute reversal of lipid-induced muscle insulin resistance is associated with rapid alteration in PKC-theta localization. (2000) (54)
- Glucose infusion causes insulin resistance in skeletal muscle of rats without changes in Akt and AS160 phosphorylation. (2007) (51)
- Independent influences of central fat and skeletal muscle lipids on insulin sensitivity. (2001) (50)
- Malonyl CoA as a metabolic switch and a regulator of insulin sensitivity. (1998) (50)
- Specific adaptations in muscle and adipose tissue in response to chronic systemic glucose oversupply in rats. (1997) (50)
- 2-deoxy-D-glucose metabolism in individual tissues of the rat in vivo. (1986) (50)
- Time Dependence of Insulin Action in Muscle and Adipose Tissue in the Rat In Vivo: An Increasing Response in Adipose Tissue with Time (1985) (49)
- Regulation of hepatic glucose output during exercise by circulating glucose and insulin in humans. (1986) (47)
- Local factors modulate tissue-specific NEFA utilization: assessment in rats using 3H-(R)-2-bromopalmitate. (2000) (47)
- Cytosolic citrate and malonyl-CoA regulation in rat muscle in vivo. (1999) (47)
- The effects of sympathetic nervous system activation and psychological stress on glucose metabolism and blood pressure in subjects with Type 2 (non-insulin-dependent) diabetes mellitus (1992) (45)
- 2–36[K4,RYYSA19–23]PP a novel Y5-receptor preferring ligand with strong stimulatory effect on food intake (2000) (43)
- Defective blood glucose counter-regulation in diabetics is a selective form of autonomic neuropathy. (1977) (41)
- The adaptor protein APPL1 increases glycogen accumulation in rat skeletal muscle through activation of the PI3-kinase signalling pathway (2011) (40)
- Growth Hormone–Induced Insulin Resistance and Its Relationship to Lipid Availability in the Rat (1996) (40)
- Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: role of the liver. (2002) (40)
- Adipose triglyceride lipase regulation of skeletal muscle lipid metabolism and insulin responsiveness. (2008) (40)
- Acute bidirectional manipulation of muscle glucose uptake by in vivo electrotransfer of constructs targeting glucose transporter genes. (2005) (39)
- Failure of insulin infusion during euglycemia to influence endogenous basal insulin secretion. (1983) (37)
- Muscle glucose uptake during and after exercise is normal in insulin-resistant rats. (1993) (36)
- Is it a consequence of AMPK downregulation (2011) (35)
- Effect of biosynthetic human growth hormone on insulin action in individual tissues of the rat in vivo. (1990) (33)
- PPARδ agonists have opposing effects on insulin resistance in high fat‐fed rats and mice due to different metabolic responses in muscle (2011) (32)
- Oscillations in blood glucose and insulin after oral glucose. (1972) (31)
- Evidence that alpha-calcitonin gene-related peptide is a neurohormone that controls systemic lipid availability and utilization. (2008) (30)
- Alteration in phosphorylation of P20 is associated with insulin resistance. (2001) (29)
- Meal‐time Intranasal Insulin Delivery in Type 2 Diabetes (1991) (28)
- Evidence that amylin stimulates lipolysis in vivo: a possible mediator of induced insulin resistance. (2001) (27)
- Nutrient Excess and AMPK Downregulation in Incubated Skeletal Muscle and Muscle of Glucose Infused Rats (2015) (27)
- Rat amylin-(8-37) enhances insulin action and alters lipid metabolism in normal and insulin-resistant rats. (1997) (26)
- Pharmacokinetics of Insulin Implications for Continuous Subcutaneous Insulin Infusion Therapy (1985) (25)
- A high-fat diet influences insulin-stimulated posttransport muscle glucose metabolism in rats. (1997) (25)
- Cytosolic citrate and malonyl-CoA regulation in rat muscle in vivo. (1999) (24)
- Peripheral insulin resistance develops in transgenic rats overexpressing phosphoenolpyruvate carboxykinase in the kidney (2003) (22)
- The Effect of Hyperinsulinemia on Glucose Homeostasis During Moderate Exercise in Man (1982) (22)
- The effect of exercise training on glycogen, glycogen synthase and phosphorylase in muscle and liver (2004) (21)
- Cardiac beat to beat variation: age related changes in the normal population and abnormalities in diabetics. (1981) (21)
- Local activation of the IκK-NF-κB pathway in muscle does not cause insulin resistance (2008) (21)
- AMP-activated protein kinase and malonyl-CoA: Targets for treating insulin resistance? (2005) (21)
- Tracer studies of in vivo insulin action and glucose metabolism in individual peripheral tissues. (1990) (18)
- Peroxisome proliferator-activated receptor (PPAR) activation induces tissue-specific effects on fatty acid uptake and metabolism in vivo--a study using the novel PPARalpha/gamma agonist tesaglitazar. (2004) (18)
- Effect of contact material on vibration-induced insulin aggregation (1984) (18)
- In vivo dose response curves of insulin action in heart: anomalous effects at high insulin doses. (1985) (16)
- In vivo insulin sensitivity of the pyruvate dehydrogenase complex in tissues of the rat. (1993) (16)
- Comparison of secretin response to oral intraduodenal or intravenous glucose administration. (1971) (16)
- AMP-activated protein kinase and muscle insulin resistance. (2009) (15)
- The evolution of insulin resistance in muscle of the glucose infused rat. (2011) (15)
- Overexpression of SIRT1 in Rat Skeletal Muscle Does Not Alter Glucose Induced Insulin Resistance (2015) (15)
- Peroxisome proliferator activated receptors, fatty acids and muscle insulin resistance. (2002) (14)
- Insulin precipitation in artificial infusion devices (1981) (14)
- Prior eccentric contractions impair maximal insulin action on muscle glucose uptake in the conscious rat. (1997) (14)
- Effect of insulin on [3H]deoxy-D-glucose pharmacokinetics in the rat. (1988) (13)
- Effects of blockade of fatty acid oxidation on whole body and tissue-specific glucose metabolism in rats. (1993) (13)
- Reduced cardiac beat-to-beta variation in chronic renal failure: a ubiquitous marker of autonomic neuropathy. (1982) (13)
- Local activation of the IkappaK-NF-kappaB pathway in muscle does not cause insulin resistance. (2008) (13)
- Development and testing of a simple algorithm for a glucose clamp (1986) (12)
- Simultaneous assay of insulin and glucagon in serum. (1968) (12)
- 35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
- Hormonal responses to insulin infusion in diabetes mellitus (1979) (10)
- Programming of Insulin Delivery with Meals During Subcutaneous Insulin Infusion (1981) (10)
- Comparison of Plateau Insulin Levels Achieved by Intravenous or Subcutaneous Insulin Infusion: Evidence for Low Rates of Subcutaneous Degradation (1983) (10)
- Quantitative Aspects of Subcutaneous Insulin Absorption (1989) (10)
- Comparison of potency of porcine insulin and semisynthetic human insulin at 3 dose levels using the euglycaemic clamp. (1983) (10)
- Development of a closed-loop artificial pancreas. (1979) (9)
- Glucose transporters and in vivo glucose uptake in skeletal and cardiac muscle: fasting, insulin cells (1994) (9)
- In vivo quantification of glucose uptake and conversion to glycogen in individual muscles of the rat following exercise. (1998) (9)
- Closure of the loop by glucose sensing. Physiological and practical considerations. (1988) (8)
- Heterogeneity of response to exercise of rat muscle pyruvate dehydrogenase complex (1991) (8)
- Minimal impact of age and housing temperature on the metabolic phenotype of Acc2-/- mice. (2016) (8)
- Hypoglycemic episodes during continuous subcutaneous insulin infusion: decreased frequency but increased susceptibility. (1984) (8)
- Ritonavir has paradoxical effects on lipid metabolism and insulin sensitivity in rats compared with humans. (1998) (7)
- Central neuropeptide Y infusion and melanocortin 4 receptor antagonism inhibit thyrotropic function by divergent pathways (2011) (7)
- Human growth hormone fragment (hGH44–191) produces insulin resistance and hyperinsulinemia but is less potent than the 22 kDa hGH in the rat (1997) (6)
- Application of Physicians' Predictions of Meal and Exercise Effects on Blood Glucose Control to a Computer Simulation (1993) (6)
- Low subcutaneous degradation and slow absorption of insulin in insulin-dependent diabetic patients during continuous subcutaneous insulin infusion at basal rate (1984) (6)
- Glycaemic response to an insulin dose change: computer simulator predictions vs mean patient responses (1994) (4)
- Glut4 Is Targeted to Secretory Granules in Rat Atrial Cardiomyocytes (1997) (4)
- Alteration in Phosphorylation of P 20 Is Associated With Insulin Resistance (2001) (4)
- Rapid pulsatile corticosterone secretion in the rat is not confirmed (1981) (4)
- Effect of procaine injection into the ventromedial hypothalamic area (VMH) of the rat on serum insulin, glucose and corticosterone and gastric emptying rate (1988) (4)
- Fatty Acids and Muscle Insulin Resistance (2002) (3)
- The adaptor protein APPL1 increases glycogen (2011) (3)
- Fat Partitioning and Insulin Sensitivity (2009) (2)
- BIOGENIC AMINES and GLUCAGON RELEASE (1977) (1)
- Oral administration of glucose promotes intracellular partitioning of fatty acid toward storage in white but not in red muscle. (2006) (1)
- Sensitivity of hepatic glucose output to blood glucose in normal subjects and type ii diabetics (1986) (0)
- Distinct Changes in Adipose Tissue and Muscle in Response to Excess Systemic Glucose in Rats (2016) (0)
- Reversal of chronic alterations of skeletal muscle protein kinase C from fat-fed rats by BRL-49653. (1997) (0)
- Peroxisome Proliferator-Activated Receptor (PPAR) Activation Induces Tissue-Specific Effects on Fatty Acid Uptake and Metabolism in Vivo —A Study Using the Novel PPAR (cid:1) / (cid:2) Agonist Tesaglitazar (2004) (0)
- INFLUENCE OF PPARs ON MUSCLE LIPID METABOLISM AND INSULIN RESISTANCE (2002) (0)
- ENDOGENOUS INSULIN SECRETION DURING LOW LEVEL INTRAVENOUS INSULIN INFUSION IN MAN (1977) (0)
- AMPK directly phosphorylates SREBP-1c at ser 372, suppresses hepatic de novo lipogenesis, and prevents hepatic steatosis in diet-induced insulin resistant mice (2011) (0)
- Feedback Control of Blood Glucose (1973) (0)
- Heterogeneity of in vivo insulin sensitivity among individual tissues studies using the euglycemic clamp in the rat (1984) (0)
- Rat amylin-(8-37) enhances insulin action and alters lipid metabolism in normal and insulin-resistant rats. (1997) (0)
- action on muscle glucose uptake in the conscious rat Prior eccentric contractions impair maximal insulin (2015) (0)
- Triterpenoids extracted from bitter melon activate AMPK via a mechanism involving the upstream AMPK kinase CaMKKa/b (2011) (0)
- glycogen synthesis in soleus muscle in vitro Effects of individual fatty acids on glucose uptake and (2016) (0)
- P-101: Alterations in the expression and cellular localization of protein kinase C isozymes are associated with insulin resistance in skeletal muscle of the high-fat-fed rat (2009) (0)
- Malonyl CoA fuel sensing mechanism in muscle of insulin resistant rodents (2009) (0)
- Unawareness of hypoglycaemia (1990) (0)
- Sobs Annual Report | | 2008 80 Primary (0)
- SIMULATION STUDIES OF THE ORAL GLUCOSE TOLERANCE TEST (1977) (0)
- muscleand insulin sensitivity in rat and human Long-chain acyl-CoA esters as indicators of lipid (2016) (0)
- An improved method for continuous on-line measurement of blood glucose (1978) (0)
- Glucagon in Diabetic Coma (1977) (0)
- Fat Partitioning and Insulin Sensitivity Robbing Peter to Pay Paul? (2008) (0)
- Muscle lipid availability and insulin resistance (2009) (0)
- Models of deoxyglucose pharmacokinetics in the rat does interstitial diffusion influence glucose uptake (1988) (0)
- Rapid handling of experimental data in radioimmunoassay (1972) (0)
- Muscle Lipid Accumulation Is Not Essential to Muscle Insulin Resistance Induced by a Chronic Glucose Oversupply (2002) (0)
- UNAWARENCE OF HYPOGLYCAEMIA (1990) (0)
- Muscle lipid accumulation and protein kinase C activation in the insulin-resistant chronically glucose-infused rat. (1999) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Edward W. Kraegen?
Edward W. Kraegen is affiliated with the following schools:
